Osteoarthritis: An overview of the disease and its treatment strategies

被引:441
作者
Sarzi-Puttini, P
Cimmino, MA
Scarpa, R
Caporali, R
Parazzini, F
Zaninelli, A
Atzeni, F
Canesi, B
机构
[1] L Sacco Univ Hosp, Rheumatol Unit, Div Rheumatol, Milan, Italy
[2] Univ Genoa, DIMI, Chair Rheumatol, Genoa, Italy
[3] Univ Naples Federico II, Chair Rheumatol, Naples, Italy
[4] Univ Pavia, Chair Rheumatol, I-27100 Pavia, Italy
[5] IRCCS Poiclin S Matteo, Pavia, Italy
[6] Ist Mario Negri, Div Epidemiol, Milan, Italy
[7] Osped Niguarda Ca Granda, Rheumatol Unit, Milan, Italy
关键词
osteoarthritis; pain; risk factors; general and specialist practice;
D O I
10.1016/j.semarthrit.2005.01.013
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Osteoarthritis (OA) is currently defined by the American College of Rheumatology as a "heterogeneous group of conditions that leads to joint symptoms and signs which are associated with defective integrity of articular cartilage, in addition to related changes in the underlying bone at the joint margins." Its prevalence after the age of 65 years is about 60% in men and 70% in women. The etiology of OA is multifactorial, with inflammatory, metabolic, and mechanical causes. A number of environmental risk factors, such as obesity, occupation, and trauma, may initiate various pathological pathways. OA indicates the degeneration of articular cartilage together with changes in subchondral bone and mild intraarticular inflammation. The principal treatment objectives are to control pain adequately, improve function, and reduce disability. Acetaminophen is frequently used for symptomatic OA with mild to moderate pain. Nonsteroidal antiinflammatory drugs (NSAIDs) are more effective in the case of moderate-severe pain, but they have an increased risk of serious upper gastrointestinal adverse events. The newer cyclooxygenase, COX-2 specific inhibitors (Coxibs) are as efficacious as traditional NSAIDs and have a better gastrointestinal safety profile. Other compounds (eg, chondroitin sulfate, diacerein, glucosamine sulfate) have a symptomatic effect that is slower and less than that of NSAIDs. The structure-modifying effects of drugs are currently being evaluated, and both glucosamine sulfate and diacerein have been shown in some trials to have a beneficial structural effect. Nonpharmacological interventions are frequently and widely used in the management of OA patients, but there is little evidence that they are effective: the best studied and most successful non pharmacological interventions are patient education, self-management, and exercise. There is some evidence for the pain-relieving efficacy of thermotherapy and transcutaneous electrical nerve stimulation (TENS) but not of electrotherapy, acupuncture, homeopathy, or manual therapy. The value of interventions aimed at improving function and maximizing independence (occupational therapy, walking aids, workplace adaptation) is also unclear. The disease course and patient's requirements often change over time, thus requiring a periodic review and readjustment of therapy rather than the rigid continuation of a single treatment.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 168 条
[1]
The role of nitric oxide in tissue destruction [J].
Abramson, SB ;
Amin, AR ;
Clancy, RM ;
Attur, M .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2001, 15 (05) :831-845
[2]
THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS OF THE HIP [J].
ALTMAN, R ;
ALARCON, G ;
APPELROUTH, D ;
BLOCH, D ;
BORENSTEIN, D ;
BRANDT, K ;
BROWN, C ;
COOKE, TD ;
DANIEL, W ;
FELDMAN, D ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
IKE, R ;
KAPILA, P ;
KAPLAN, D ;
KOOPMAN, W ;
MARINO, C ;
MCDONALD, E ;
MCSHANE, DJ ;
MEDSGER, T ;
MICHEL, B ;
MURPHY, WA ;
OSIAL, T ;
RAMSEYGOLDMAN, R ;
ROTHSCHILD, B ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1991, 34 (05) :505-514
[3]
THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS OF THE HAND [J].
ALTMAN, R ;
ALARCON, G ;
APPELROUTH, D ;
BLOCH, D ;
BORENSTEIN, D ;
BRANDT, K ;
BROWN, C ;
COOKE, TD ;
DANIEL, W ;
GRAY, R ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
IKE, R ;
KAPILA, P ;
KAPLAN, D ;
KOOPMAN, W ;
LONGLEY, S ;
MCSHANE, DJ ;
MEDSGER, T ;
MICHEL, B ;
MURPHY, W ;
OSIAL, T ;
RAMSEYGOLDMAN, R ;
ROTHSCHILD, B ;
STARK, K ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1990, 33 (11) :1601-1610
[4]
DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE [J].
ALTMAN, R ;
ASCH, E ;
BLOCH, D ;
BOLE, G ;
BORENSTEIN, D ;
BRANDT, K ;
CHRISTY, W ;
COOKE, TD ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
KAPLAN, D ;
KOOPMAN, W ;
LONGLEY, S ;
MANKIN, H ;
MCSHANE, DJ ;
MEDSGER, T ;
MEENAN, R ;
MIKKELSEN, W ;
MOSKOWITZ, R ;
MURPHY, W ;
ROTHSCHILD, B ;
SEGAL, M ;
SOKOLOFF, L ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :1039-1049
[5]
Altman RD, 1998, J RHEUMATOL, V25, P2203
[6]
Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905
[7]
ALTMAN RD, 1995, J RHEUMATOL, V22, P42
[8]
American Pain Society, 2002, GUID MAN PAIN OST RH
[9]
COX-2, NO, and cartilage damage and repair. [J].
Amin A.R. ;
Dave M. ;
Attur M. ;
Abramson S.B. .
Current Rheumatology Reports, 2000, 2 (6) :447-453
[10]
A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases [J].
Amin, AR ;
Attur, MG ;
Thakker, GD ;
Patel, PD ;
Vyas, PR ;
Patel, RN ;
Patel, IR ;
Abramson, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :14014-14019